Patients treated with HBBL step-down had a higher risk of 60-day recurrence (2.19 [95% CI, .95–5.01]; P = .06), although this difference did not reach statistical significance in the primary model ( Figure 2 ).
← all excerpts
Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated <i>Escherichia coli</i> or <i>Klebsiella</i> Species Bacteremia From a Urinary Tract Source.
1
—
—